Mid-Morning May Be Best Time for Workday Break

This article originally appeared here.
Share this content:
Mid-Morning May Be Best Time for Workday Break
Mid-Morning May Be Best Time for Workday Break

FRIDAY, Sept. 18, 2015 (HealthDay News) -- Choosing preferred activities for a work break and taking a break earlier in the shift are linked to more resource recovery after a break, according to a study published online Aug. 10 in the Journal of Applied Psychology.

Emily M. Hunter, Ph.D., and Cindy Wu, Ph.D., from Baylor University in Waco, Texas, examined the characteristics of employee workday breaks with 95 employees across five workdays. They further investigated resources as a mediator between break characteristics and well-being.

The researchers found that there was more resource recovery after the break for break activities that were preferred and earlier in the work shift, based on multilevel analysis. Resources were found to mediate the influence of preferred break activities and time of break on health symptoms. Recovery of resources was found to benefit person-level outcomes (emotional exhaustion, job satisfaction, and organizational citizenship behavior). There was an interaction between break length and number of breaks per day, with longer breaks and frequent short breaks correlating with more resources than infrequent short breaks.

"Our results suggest that computer workers can reap the most benefits from their workday breaks if they engage in break activities that they prefer and if they pay attention to the timing of their breaks," the authors write. "We also found preliminary evidence that break length and number of breaks per day together are important for recovering resources."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »